The FDA has just handed an advantage to GlaxoSmithKline’s triple therapy for chronic obstructive pulmonary disease (COPD) by rejecting AstraZeneca’s PT010, a close competitor. AZ has confirmed that ...
The generic drug, montelukast should be offered to people ahead of combination inhalers such as GlaxoSmithKline's Seretide, in a bid to save the NHS millions of pounds, according to draft guidance ...
Many parents, families and students express interest about the requirements for New York State resident tuition. The difference between the resident and non-resident tuition rates is significant, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results